Found: 55
Select item for more details and to access through your institution.
EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 527, doi. 10.1007/s40259-014-0106-1
- By:
- Publication type:
- Article
Role of Embedded Pure Xenogenous Bovine Platelet Gel on Experimental Tendon Healing, Modelling and Remodelling.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 537, doi. 10.1007/s40259-014-0107-0
- By:
- Publication type:
- Article
Demonstration of Biosimilarity, Extrapolation of Indications and Other Challenges Related to Biosimilars in Europe.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 479, doi. 10.1007/s40259-014-0109-y
- By:
- Publication type:
- Article
Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 513, doi. 10.1007/s40259-014-0111-4
- By:
- Publication type:
- Article
Acknowledgement to Referees.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 477, doi. 10.1007/s40259-014-0112-3
- Publication type:
- Article
The Role of Interleukin-17A in Psoriatic Disease.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 487, doi. 10.1007/s40259-014-0098-x
- By:
- Publication type:
- Article
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 499, doi. 10.1007/s40259-014-0100-7
- By:
- Publication type:
- Article
Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin).
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 451, doi. 10.1007/s40259-014-0103-4
- By:
- Publication type:
- Article
Making Choices: Health Consumers, Regulation and the Global Stem Cell Therapy Market.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 461, doi. 10.1007/s40259-014-0105-2
- By:
- Publication type:
- Article
Elosulfase Alfa: A Review of Its Use in Patients with Mucopolysaccharidosis Type IVA (Morquio A Syndrome).
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 465, doi. 10.1007/s40259-014-0108-z
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 421, doi. 10.1007/s40259-014-0097-y
- By:
- Publication type:
- Article
Similar Names for Similar Biologics.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 439, doi. 10.1007/s40259-014-0099-9
- By:
- Publication type:
- Article
Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 445, doi. 10.1007/s40259-014-0101-6
- By:
- Publication type:
- Article
Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 411, doi. 10.1007/s40259-014-0104-3
- By:
- Publication type:
- Article
siRNA Technology in Kidney Transplantation: Current Status and Future Potential.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 345, doi. 10.1007/s40259-014-0087-0
- By:
- Publication type:
- Article
Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 363, doi. 10.1007/s40259-014-0088-z
- By:
- Publication type:
- Article
Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 393, doi. 10.1007/s40259-014-0089-y
- By:
- Publication type:
- Article
Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 373, doi. 10.1007/s40259-014-0090-5
- By:
- Publication type:
- Article
Multi-Specific Antibodies for Cancer Immunotherapy.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 331, doi. 10.1007/s40259-014-0091-4
- By:
- Publication type:
- Article
Unexplained Abuses of Human IgG Subclass Denomination in Antibody Patents.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 327, doi. 10.1007/s40259-014-0095-0
- By:
- Publication type:
- Article
Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody-Drug Conjugates.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 383, doi. 10.1007/s40259-014-0096-z
- By:
- Publication type:
- Article
Ranibizumab: A Review of its Use in Myopic Choroidal Neovascularization.
- Published in:
- BioDrugs, 2014, v. 28, n. 4, p. 403, doi. 10.1007/s40259-014-0102-5
- By:
- Publication type:
- Article
Erratum to: Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML).
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 325, doi. 10.1007/s40259-014-0093-2
- By:
- Publication type:
- Article
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 285, doi. 10.1007/s40259-014-0084-3
- By:
- Publication type:
- Article
Bacteriophage Polysaccharide Depolymerases and Biomedical Applications.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 265, doi. 10.1007/s40259-013-0081-y
- By:
- Publication type:
- Article
Erratum to: Bacteriophage Polysaccharide Depolymerases and Biomedical Applications.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 323, doi. 10.1007/s40259-014-0092-3
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 275, doi. 10.1007/s40259-013-0079-5
- By:
- Publication type:
- Article
Management of Relapsed or Refractory Hodgkin Lymphoma with Second-Generation Antibody-Drug Conjugates: Focus on Brentuximab Vedotin.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 245, doi. 10.1007/s40259-013-0077-7
- By:
- Publication type:
- Article
Attenuation of Carbon Tetrachloride-Induced Hepatic Injury with Curcumin-Loaded Solid Lipid Nanoparticles.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 297, doi. 10.1007/s40259-014-0086-1
- By:
- Publication type:
- Article
Calcitonin Gene-Related Peptide Targeted Immunotherapy for Migraine: Progress and Challenges in Treating Headache.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 237, doi. 10.1007/s40259-014-0083-4
- By:
- Publication type:
- Article
A Review of CT-P13: An Infliximab Biosimilar.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 313, doi. 10.1007/s40259-014-0094-1
- By:
- Publication type:
- Article
Management of Metastatic Breast Cancer with Second-Generation Antibody-Drug Conjugates: Focus on Glembatumumab Vedotin (CDX-011, CR011-vcMMAE).
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 253, doi. 10.1007/s40259-014-0085-2
- By:
- Publication type:
- Article
Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective.
- Published in:
- BioDrugs, 2014, v. 28, p. 5, doi. 10.1007/s40259-013-0063-0
- By:
- Publication type:
- Article
How FABulous is PEGgy? Certoliziumab Pegol from the Bench to the Patients.
- Published in:
- BioDrugs, 2014, v. 28, p. 3, doi. 10.1007/s40259-013-0067-9
- By:
- Publication type:
- Article
Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol.
- Published in:
- BioDrugs, 2014, v. 28, p. 15, doi. 10.1007/s40259-013-0064-z
- By:
- Publication type:
- Article
Efficacy and Safety of Certolizumab Pegol in Rheumatoid Arthritis: Meeting Rheumatologists' Requirements in Routine Clinical Practice.
- Published in:
- BioDrugs, 2014, v. 28, p. 25, doi. 10.1007/s40259-013-0065-y
- By:
- Publication type:
- Article
Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol.
- Published in:
- BioDrugs, 2014, v. 28, p. 1, doi. 10.1007/s40259-013-0080-z
- Publication type:
- Article
Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 145, doi. 10.1007/s40259-013-0062-1
- By:
- Publication type:
- Article
Efficacy and Safety of Biologic Therapies for Systemic Lupus Erythematosus Treatment: Systematic Review and Meta-Analysis.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 211, doi. 10.1007/s40259-013-0074-x
- By:
- Publication type:
- Article
Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and Chemotherapy.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 133, doi. 10.1007/s40259-013-0066-x
- By:
- Publication type:
- Article
Interferon-Free Regimens for Hepatitis C: Combine and Conquer.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 161, doi. 10.1007/s40259-013-0072-z
- By:
- Publication type:
- Article
CD30 as a Therapeutic Target for Lymphoma.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 181, doi. 10.1007/s40259-013-0068-8
- By:
- Publication type:
- Article
Antibody-Cytokine Fusion Proteins for Cancer Immunotherapy: An Update on Recent Developments.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 123, doi. 10.1007/s40259-013-0069-7
- By:
- Publication type:
- Article
Genetically Engineered Humanized Mouse Models for Preclinical Antibody Studies.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 171, doi. 10.1007/s40259-013-0071-0
- By:
- Publication type:
- Article
Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative US Claims Database.
- Published in:
- BioDrugs, 2014, v. 28, n. 2, p. 229, doi. 10.1007/s40259-013-0073-y
- By:
- Publication type:
- Article
A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin.
- Published in:
- BioDrugs, 2014, v. 28, n. 1, p. 63, doi. 10.1007/s40259-013-0055-0
- By:
- Publication type:
- Article
Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France.
- Published in:
- BioDrugs, 2014, v. 28, n. 1, p. 55, doi. 10.1007/s40259-013-0054-1
- By:
- Publication type:
- Article
Evidence for the Use of Biological Therapies in Ulcers of the Foot in Diabetes.
- Published in:
- BioDrugs, 2014, v. 28, n. 1, p. 1, doi. 10.1007/s40259-013-0052-3
- By:
- Publication type:
- Article
Bosutinib: A Review of Its Use in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia.
- Published in:
- BioDrugs, 2014, v. 28, n. 1, p. 107, doi. 10.1007/s40259-013-0082-x
- By:
- Publication type:
- Article
Treg Vaccination in Autoimmune Type 1 Diabetes.
- Published in:
- BioDrugs, 2014, v. 28, n. 1, p. 7, doi. 10.1007/s40259-013-0060-3
- By:
- Publication type:
- Article